CENTENNIAL, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) (“Inhibiton” or the “Company”) announced today that it is moving forward under its previously announced Agreement in Principle to acquire HPI Partners, LLC (“HPIP”) and its operating subsidiary AlumiFuel Power, Inc. (“APl”) of Philadelphia, Pennsylvania. HPIP, through API, is an alternative energy company that is working to commercialize a process for generating hydrogen gas and steam on-site and on-demand for multiple niche applications. The parties are targeting to complete the definitive agreement in late January.
